Literature DB >> 19800062

Longitudinal assessment of antimüllerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin.

Scott M Nelson1, Frances Stewart, Richard Fleming, Dilys J Freeman.   

Abstract

We examined in a prospective longitudinal pregnancy cohort the influence of advancing gestation and baseline maternal adiposity on antimüllerian hormone (AMH) and determined whether maternal hormones (insulin, leptin, adiponectin, E(2), and sex hormone-binding globulin) correlate with alterations in AMH. We demonstrate that first-trimester AMH is associated negatively with maternal adiposity, that circulating levels decline during the second and third trimesters of pregnancy, and that in univariate and multivariate models adiponectin is associated positively with AMH during this period of pregnancy-related decline. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800062     DOI: 10.1016/j.fertnstert.2009.07.1676

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  25 in total

1.  Anti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability.

Authors:  Donna D Baird; Anne Z Steiner
Journal:  Am J Epidemiol       Date:  2012-01-12       Impact factor: 4.897

2.  The original Beckman Coulter Generation II assay significantly underestimates AMH levels compared with the revised protocol.

Authors:  Michael Bonifacio; Cara K Bradley; Sonal Karia; Mark Livingstone; Mark C Bowman; Steven J McArthur
Journal:  J Assist Reprod Genet       Date:  2015-10-14       Impact factor: 3.412

3.  Anti-Müllerian Hormone Levels and Urinary Cortisol in Women With Chronic Abdominal Pain.

Authors:  Theresa M Hardy; Donna O McCarthy; Nicolaas H Fourie; Wendy A Henderson
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2016-09-14

4.  Anti-Mullerian hormone normogram in an Irish subfertile population.

Authors:  M N Naasan; C Harrity; L Pentony; E Mocanu
Journal:  Ir J Med Sci       Date:  2014-02-23       Impact factor: 1.568

5.  Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers.

Authors:  M A Spath; T B Feuth; E G Allen; A P T Smits; H G Yntema; A Geurts van Kessel; D D M Braat; S L Sherman; C M G Thomas
Journal:  Hum Reprod       Date:  2011-05-15       Impact factor: 6.918

6.  Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH.

Authors:  Crystal Chan; Kimberly Liu
Journal:  J Assist Reprod Genet       Date:  2014-08-12       Impact factor: 3.412

7.  Anti-mullerian hormone concentration during the third trimester of pregnancy and puerperium: a longitudinal case-control study in normal and diabetic pregnancy.

Authors:  Sandro Gerli; Alessandro Favilli; Annalisa Brozzetti; Elisabetta Torlone; Brunella Pugliese; Silvia Pericoli; Vittorio Bini; Alberto Falorni
Journal:  Endocrine       Date:  2014-12-25       Impact factor: 3.633

8.  Predicting fertility with antimüllerian hormone: is a cutoff value adequate?

Authors:  Katherine S Anderson; James H Segars
Journal:  Fertil Steril       Date:  2012-10-01       Impact factor: 7.329

9.  Serum anti-Müllerian hormone levels in women are unstable in the postpartum period but return to normal within 5 months: a longitudinal study.

Authors:  Michael W Pankhurst; Annelien C de Kat; Shirley Jones; Frank J M Broekmans; Benjamin J Wheeler
Journal:  Endocrine       Date:  2020-09-11       Impact factor: 3.633

10.  Exploring the Ovarian Reserve Within Health Parameters: A Latent Class Analysis.

Authors:  Theresa M Hardy; Mauricio Garnier-Villarreal; Donna O McCarthy; Richard A Anderson; Rebecca M Reynolds
Journal:  West J Nurs Res       Date:  2018-08-09       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.